GlaxoSmithKline (GSK)

Add to Watchlists Create an Alert
53.24 -0.15  -0.28% NYSE Jul 22, 4:59PM BATS Real time Currency in USD

GlaxoSmithKline Total Liabilities (Quarterly):

54.83B for March 31, 2014

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Total Liabilities (Quarterly) Chart

Export Data
Save Image

GlaxoSmithKline Historical Total Liabilities (Quarterly) Data

View and export this data going back to 1986. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
March 31, 2014 54.83B
Dec. 31, 2013 57.59B
Sept. 30, 2013 56.40B
June 30, 2013 54.75B
March 31, 2013 54.97B
Dec. 31, 2012 57.56B
Sept. 30, 2012 55.52B
June 30, 2012 55.14B
March 31, 2012 50.95B
Dec. 31, 2011 51.44B
Sept. 30, 2011 52.62B
June 30, 2011 53.50B
March 31, 2011 53.90B
Dec. 31, 2010 51.47B
Sept. 30, 2010 51.69B
June 30, 2010 51.50B
March 31, 2010 50.68B
Dec. 31, 2009 52.63B
Sept. 30, 2009 51.45B
June 30, 2009 46.54B
March 31, 2009 44.80B
Dec. 31, 2008 46.05B
Sept. 30, 2008 48.26B
June 30, 2008 49.86B
March 31, 2008 42.78B
   
Dec. 31, 2007 42.59B
Sept. 30, 2007 36.09B
June 30, 2007 32.08B
March 31, 2007 32.27B
Dec. 31, 2006 31.66B
Sept. 30, 2006 31.51B
June 30, 2006 32.26B
March 31, 2006 33.34B
Dec. 31, 2005 34.33B
Sept. 30, 2005 33.30B
June 30, 2005 33.26B
March 31, 2005 32.65B
Dec. 31, 2004 32.25B
Sept. 30, 2004 29.08B
June 30, 2004 29.49B
March 31, 2004 27.99B
Dec. 31, 2003 28.83B
Sept. 30, 2003 27.20B
June 30, 2003 26.40B
March 31, 2003 24.24B
Dec. 31, 2002 25.20B
Sept. 30, 2002 23.78B
June 30, 2002 23.90B
March 31, 2002 21.88B
Dec. 31, 2001 20.84B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Get data for
Advertisement

GSK Total Liabilities (Quarterly) Benchmarks

Companies
AstraZeneca 37.94B
Pfizer 94.04B
Novartis 55.38B

GSK Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 50.68B Mar 2010
Maximum 57.59B Dec 2013
Average 53.61B

GSK Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("GSK", "liabilities")
  • Last 5 data points: =YCS("GSK", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.